ABSTRACT SMCT1 (slc5a8) is a sodium-coupled monocarboxylate transporter expressed in the brush border of enterocytes. It regulates the uptake of short-chain fatty acids (SCFAs) produced by bacterial fermentation in the large intestine. Another subtype, SMCT2 (slc5a12), is expressed abundantly in the small intestine, but its precise expression profile remains unknown. The present study using in situ hybridization method, immunohistochemistry, and quantitative PCR analysis examined the distribution and cellular localization of SMCT2 in the digestive tract of mice and compared the expression pattern with those of other transporters for monocarboxylates. While an abundant expression of SMCT2 was found in the jejunum, this was negligible in the duodenum, terminal ileum, and large intestine. In contrast, SMCT1 had predominant expression sites in the large bowel and terminal ileum. Subcellularly, SMCT2 was localized in the brush border of enterocytes in the intestinal villi-as is the case for SMCT1, suggesting its involvement in the uptake of foodderived monocarboxylates such as lactate and acetate. MCT (slc16) is a basolateral type transporter of the gut epithelium and conveys monocarboxylates in an H + -dependent manner. Since among the main subtypes of MCT family only MCT1 was expressed significantly in the small intestine, it is able to function as a counterpart to SMCT2 in this location.
Plant-derived dietary fibers and undigested carbohydrates are fermented by bacterial microflora in the large intestine, resulting in the production of acetate, propionate, and butyrate, collectively called shortchain fatty acids (SCFAs). SCFAs are further classified into monocarboxylates together with lactate and ketone bodies. SCFAs are absorbed via the epithelium of the large intestine and serve as energy substrates to various extents. Their contribution as an energy source for the whole body may be low as compared with glucose, but this increases under some conditions such as starvation. In 2004, slc5a8 was found to code for a Na + -coupled transporter for SCFAs, lactate, and pyruvate (2, 7, 12 ) and termed a sodium-dependent monocarboxylate transporter (SMCT). The large intestine can incorporate SCFAs by SMCT expressed in the brush border of enterocytes (15). It is reasonable that the predominant expression site of SMCT is the large intestine, being associated with the vigorous fermentation of dietary fibers. Srinivas et al. (14) identified another type of SMCT (SMCT2 or slc5a12) with 59% identity with SMCT1 at the amino acid level. This novel SMCT subtype mediates the sodium-dependent transport of various monocarboxylates with low affinity as compared with SMCT1. The intense expression of SMCT2 has been noted in the kidney, skeletal muscle, and small intestine but is absent in the cecum stock; Nihon Nosan Kogyo, Tokyo, Japan) and water for an acclimatization period of 7 days. After the acclimatization, all mice were fasted overnight. Fasting started at 6 : 00 PM on the day before sampling, and the dissection was performed at 9 : 00-10 : 00 AM (15-16 h fasting). Each mouse was anaesthetized with an intraperitoneal injection of sodium pentobarbital (Schering-Plough, Osaka, Japan) and then exsanguinated. The entire digestive tract, from the cardiac end of the stomach to the anus, was dissected out. The samples for in situ hybridization and immunohistochemical analyses were collected from three of the six mice, and the samples for real-time PCR analysis were from the other three mice. For in situ hybridization and immunohistochemical analyses, 5 and 3 segments respectively from the small and large intestines were collected and termed as D (duodenum), J-1, J-2 (jejunum), I-1, I-2 (ileum), Ce (cecum), Co (colon), and R (rectum), as indicated in Fig. 1 . The obtained tissues were washed with physiological saline and directly embedded into a freezing medium (OCT compound; Sakura Finetechnical Co. Ltd., Tokyo, Japan). The embedded tissues were quickly frozen in liquid nitrogen and stored at −80°C until use. For immunohistochemistry, the animals were deeply anesthetized by an intraperitoneal injection of pentobarbital and then perfused through the left ventricle of the heart with physiological saline and subsequently with 4% paraformaldehyde in 0.1 M phosphate buffer, pH 7.4. Tissue samples were obtained from the J-2 region (middle of small intestine) and immersed in the same fixative for an additional 6 h. The fresh samples from the J-2 were directly immersed in Bouin's fluid for 12 h and processed to paraffin sections for conventional immunohistochemistry. This experiment was conducted in accordance with both of the guidelines for studies with laboratory animals of the Kyoto Prefectural University Experimental Animal Committee and the Guidelines for Animal Experimentation, Graduate School of Medicine, Hokkaido University.
In situ hybridization. Two non-overlapping antisense oligonucleotide probes (45 mer in length) were designed for each mRNA of mouse SMCT1, MCT1, MCT2, MCT4, and MCT5, as described in our previous study (11, 16) . Antisense probes for SMCT2 were newly designed to be complementary to the 668-712 and 1670-1714 of mouse slc5a12 (accession number: AY964639). The probes were labeled with 33 P-dATP using terminal deoxynucleoand colon (14). SMCT1 and SMCT2 in the kidney display varying distribution patterns along the proximal tubules and may effectively re-absorb lactate in glomerular filtrates by use of their different affinities to substrates (8) . Since the detailed distribution and functional significance of SMCT2 in the intestine remain unknown, the present study aimed to reveal the cellular localization of SMCT2 at mRNA and protein levels in the murine gastrointestinal tract, with reference to other transporters for monocarboxylates.
The intestine is rich in another family of transporters for monocarboxylates, MCT (slc16) (4, 11) .
MCT is a basolateral type of transporter in the gastrointestinal tract and may be involved in transfer of absorbed monocarboxylates toward the blood circulation (11) . In the present study, MCT1-MCT5 (except retina-specific MCT3) as well as SMCTs were quantitatively analyzed by real-time PCR using a total of 28 segments from the stomach to the anus.
MATERIALS AND METHODS

Specific antibody for SMCT2.
A polyclonal antibody to mouse SMCT2 was raised against the amino acid residues 567-619. The polypeptide was expressed as glutathione S-transferase (GST) fusion proteins using the pGEX4T-2 vector (GE Healthcare Biosciences, Uppsala, Sweden) and BL21 cells (TAKARA, Tokyo, Japan). The fusion protein was purified with glutathione-Sepharose 4B (GE Healthcare Biosciences), emulsified with Freund's complete or incomplete adjuvant (Difco, Detroit, MI), and injected subcutaneously into female New Zealand White rabbits and Hartley guinea pigs (Japan SLC, Shizuoka, Japan) at intervals of 2 weeks. Ten days after the fifth injection, affinity purified antibodies were prepared from the serum, first using Protein G-Sepharose (GE Healthcare Biosciences) and then using antigen peptides coupled to CNBr-activated Sepharose 4B (GE Healthcare Biosciences). For preparation of the affinity media, antigen peptides free from GST were obtained by the elution of cleaved polypeptides after the in-column digestion by thrombin (Sigma, St. Louis, MO).
Animals. Six male BALB/c mice at 8 weeks of age were purchased from Japan SLC. The mice were housed under non-barrier circumstances in our animal facilities with a controlled temperature (23 ± 1°C), relative humidity (40-60%), and lighting (lights on 09 : 00-21 : 00). They were allowed ad libitum access to normal rodent chow (Labo-MR according to Garcia et al. (5) , were subjected to 7.5% sodium dodecyl sulfate polyacrylamide gel electrophoresis under reducing conditions. The proteins were then transferred to polyvinylidine difluoride membranes (Hypond-P; GE Healthcare Biosciences) and incubated with the guinea pig antibody against SMCT2 (0.05 μg/mL). The bound antibodies were visualized using peroxidase-labeled anti-guinea pig IgG (1 : 4,000 in dilution; Dako Japan, Tokyo) and an enhanced chemiluminescence system (ECL-plus; GE Healthcare Biosciences).
Immunohistochemistry. The paraformaldehyde-fixed tissues were dipped in 30% sucrose solution overnight at 4°C, embedded in OCT compound, and quickly frozen in liquid nitrogen. Frozen sections, about 10 μm in thickness, were mounted on poly-Llysine-coated glass slides and stained by the indirect immunoperoxidase method for the guinea pig antibody against SMCT2 or avidin-biotin complex (ABC) method for the rabbit antibody. They were pretreated both with 0.3% Triton X-100-containing PBS (pH 7.2) to enhance the penetration of antibodies and with 0.03% H 2 O 2 in methanol to block endogeneous peroxidase activities. Bouin-fixed paraffin sections were de-waxed and also processed with the following common steps. After preincubation with normal goat serum, the frozen and paraffin sections were incubated overnight with the guinea pig antibody (1 μg/mL at concentration) or rabbit antibody (2 μg/mL) against SMCT2. They were then incubated with either peroxidase-labeled anti-guinea pig IgG (P0141; Dako Japan) or biotinylated goat antirabbit immunoglobulins (Nichirei, Tokyo, Japan) followed by incubation with the avidin-peroxidase tidyl transferase (Invitrogen, Carlsbad, CA). Fresh frozen sections, 14-μm-thick, were fixed with 4% paraformaldehyde in 0.1 M phosphate buffer for 15 min, and then acetylated with 0.25% acetic anhydride in 0.1 M triethanolamine-HCl (pH 8.0) for 10 min. Hybridization was performed at 42°C for 10 h with a hybridization buffer containing 10,000 cpm/μL 33 P-labeled oligonucleotide probe. Glass slides were rinsed at room temperature for 30 min in 2 × SSC (1 × SSC: 150 mM sodium chloride, 15 mM sodium citrate) containing 0.1% Nlauroylsarcosine sodium, then rinsed twice at 55°C for 40 min in 0.1 × SSC containing 0.1% N-lauroylsarcosine sodium, dehydrated through a graded series of ethanol, and air-dried. Sections were either exposed to BioMax MR film (Kodak, Rochester, NY) for 10 days or dipped in auroradiographic emulsion (NTB-2, Kodak) at 4°C for 8-12 weeks. The hybridized sections used for autoradiography were counterstained with hematoxylin after development. In situ hybridization using the two non-overlapping antisense probes for each mRNA exhibited identical labeling in all the tissues examined. The specificity of the hybridization was also confirmed by the disappearance of the signals upon the addition of an excess of an unlabeled antisense probe as a negative control.
Western blot analysis. The duodenum, jejunum (J-2), and colon were homogenized with an ice-cold 10 mM Tris-HCl buffer (pH 7.0) containing 1 mM ethylenediamine-tetraacetic acid, 20 mM KCl, and a protease inhibitor cocktail (Complete Mini; Roche, Mannheim, Germany). Soluble fractions, processed ReverTra Ace qPCR RT Kit (TOYOBO, Osaka, Japan) according to the manufacturer's instructions. Real-time PCR was performed using a LightCycler 480 (Roche Applied Science, Tokyo, Japan). The expressions of 6 genes, SMCT1, SMCT2, and MCT1-MCT5 (except MCT3), were evaluated in each segment of the gastrointestinal tract. For the housekeeping gene, the expression of β-actin was assessed, since our preliminary study using external control RNA indicated that expression levels of other housekeeping genes, such as glyceraldehyde-3-phosphate dehydrogenase (GAPDH), hypoxantin phosphoribosyl transferase (HPRT) and 18S ribosomal RNA (18S rRNA) differed considerably among the tissues (data not shown). Specific primers and probe sets for each gene were designed according to the GenBank accession number with online software provided by Roche Applied Science (https://www.roche-applied-science.com/). PCR for all genes was performed under following conditions: an initial denaturation at 95°C for 5 min, followed by 50 cycles of denaturation at 95°C for 10 s and combined annealing-extension at 60°C for 30 s. All reactions were conducted with LightCycler 480 Probes Master and Universal ProbeLibrary Set (Roche) according to the manufacturer's instructions.
RESULTS
In situ hybridization analysis for SMCT1 and SMCT2
The messenger RNA expression of two SMCT subtypes in the digestive tract of mice was compared by in situ hybridization technique (Fig. 2) . X-ray film images of hybridized sections for SMCT2 mRNA showed its restricted expression from the jejunum (J-1) to the proximal ileum (I-1) (Fig. 2) . The duodenum (D), terminal ileum (I-2), and all regions of large intestine lacked any significant mRNA expression. The most intense signals of SMCT2 in the intestine were detectable in the jejunum (J-1 and J-2), namely, the proximal half of the small intestine except the duodenum. On the other hand, SMCT1 was predominantly expressed in the terminal ileum (I-2) and large intestine, as reported previously (15). The expression patterns of SMCT1 and SMCT2 were complimentary along the longitudinal axis of the intestine and confirmed by quantitative PCR analysis (Fig. 7) . Light microscopic observation of hybridized sections showed that the signals for SMCT2 were restricted to the villous epithelium and not detectable complex (Vestastain ABC kit; Vector, Burlimgame, CA), each for 1 h. The antigen-antibody reaction was visualized by incubation in 0.05 M Tris-HCl buffer (pH 7.6) containing 0.01% 3,3'-diaminobenzidine and 0.001% H 2 O 2 .
Double immunofluorecence staining.
Frozen sections were incubated with the guinea pig anti-SMCT2 antibody (2 μg/mL) overnight, followed by incubation with Cy3-labeled donkey anti-guinea pig IgG (1 : 200 in dilution; Jackson ImmunoResearch, West Grove, PA). After rinsing in PBS, the same sections were incubated with the goat anti-SGLT1 antibody (sc-20582; Santa Cruz Biotechnology, Santa Cruz, CA) diluted 1:200 overnight, followed by incubation with FITC-labeled donkey anti-goat IgG (1 : 200; Jackson ImmunoResearch), and observed under a confocal laser scanning microscope (Fluoview; Olympus, Tokyo, Japan).
Silver-intensified immunogold method for electron microscopy. Frozen sections, 15 μm in thickness, were prepared from the paraformaldehyde-fixed tissues of the mouse jejunum and processed for the silver-intensified immunogold method. These sections on glass slides were incubated with the guinea pig anti-SMCT2 antibody (1 μg/mL) overnight and subsequently reacted with goat anti-guinea pig IgG covalently linked to 1.4-nm gold particles (1 : 150; Nanoprobe, Yaphank, NY). Following silver enhancement using HQ silver (Nanoprobes), the sections were osmificated, dehydrated, and directly embedded in Epon (Nisshin EM, Tokyo, Japan). Ultrathin sections were prepared and stained with an aqueous solution of uranyl acetate and lead citrate for observation under an electron microscope (H-7100; Hitachi, Tokyo, Japan).
Real-time PCR.
For real-time PCR analysis, we obtained a total of 28 segments of the gastrointestinal tract ( Fig. 1) : three segments from the stomach, twenty segments from the small intestine, and five segments from the large intestine (one from the cecum and four from the colon-rectum). All samples were immersed in RNAlater (Sigma, Tokyo, Japan) overnight at 4°C and then stored at −80°C until further analysis. Total RNA was extracted from each tissue stored in RNAlater and purified with QuickGene RNA tissue kit S II (FUJIFILM, Tokyo, Japan) and RNasefree DNase set (TAKARA, Shiga, Japan) according to the manufacturer's instructions. cDNA was then synthesized from 150 ng of the total RNA with in crypt regions (Fig. 3) . The signals were weak around the base of intestinal villi, became intense in their middle region, and decreased in intensity towards the villus tips throughout the small intestine. The expression gradient on the crypt-villus axis was more evident in the J-2 and I-1 portions than the J-1 portion.
Immunohistochemistry
Both guinea pig and rabbit antibodies against 567-619 of mouse SMCT2 produced a positive and specific immunoreactivity for SMCT2 on paraffin and frozen sections from the mouse jejunum. Western blot analysis of the extract from the jejunum detected a major immunoreactive band around the estimated molecular weight (68 kDa) but not in lanes of the duodenum or colon (Fig. 4) . Under the light microscope, the immunoreactivity for SMCT2 in the jejunum was found specifically in the brush border of the villous epithelium (Fig. 5a, b) . It was intense at the upper half of villi but faint at the lower half. The villous tips were frequently free from the immunoreacticity or possessed less intense immunoreactivity as compared with the middle portion of the intestinal villi. Goblet cells lacked any positive immunoreaction for SMCT2. Double immunostaining for SMCT2 and SGLT1, a major sodiumdependent glucose transporter, demonstrated the co-expression of two transporters along the brush border (Fig. 5c-e) . However, the lower part of the intestinal villi possessed only the SGLT1 immunoreactivity in the brush border. No immunoreactivity for SMCT2 was found in the brush border of the duodenum and large intestine. Electron-microscopically, gold particles showing the existence of SMCT2 immunoreactivity were localized in the brush border of absorptive cells (Fig. 6 ). Goblet cells, Paneth cells, and intraepithelial lymphocytes lacked any immunoreactivity.
Real-time PCR
When a total of 28 segments from the stomach to the rectum were analyzed by the quantitative-PCR method, the mRNA expression of SMCT1 (slc5a8) was seen to peak at the large intestine (Fig. 7) . A significant expression of SMCT1 also appeared in the distal one third of the small intestine (No. 15-20 of total 20 segments of small intestine) and gradually increased in intensity toward the rectum. In contrast, SMCT2 expression predominated in the proximal half of the small intestine (No. 3-12 of small intestine), again showing a complimentary pattern against SMCT1 on the anterior-posterior axis of gut. The complete lack of the expression for SMCT2 mRNA in the large intestine was clearly indicated by the present quantitative PCR analysis. tine. The mRNA expressions of MCT2 and MCT5 were restricted essentially to the glandular stomach. The expression pattern of MCT2 is consistent with the finding that parietal cells are the main source of MCT2 throughout the digestive tract (5). As for MCT4, a significant expression was recognizable only in the duodenum (No. 3 of small intestine in Fig. 7) , while other regions of the intestine did not show any significant expression.
DISCUSSION
SMCT2 is a jejunal type of SMCT
The expression of SMCT2 in the mouse gut was restricted to the small intestine and showed a distribution pattern different from that of SMCT1, being largely in agreement with the findings from Northern blot and RT-PCR analyses by Srinivas et al. (14) . Because of its total absence in the duodenum and terminal ileum as revealed by the present in situ hybridization study, we can recognize SMCT2 as a jejunal type of SMCT. The selective localization of SMCT2 at the brush border was confirmed by our electron microscopic observation and double immunostaining with SGLT1 (sodium-dependent glucose transporter). This finding supports the involvement MCT1, a major subtype among the MCT family, showed the most intense expression in the large intestine and also a broad distribution from the stomach to the terminal ileum, though the intensity was considerably lower in the stomach and small intes- namely the S1 to S3 segments. We recognized an intense immunoreactivity of SMCT2 in the S1 segment, but the degree of expression of SMCT2 was very low in the S2 and S3 segments, which intensely expressed SMCT1 (16 and our unpublished data). Our immunostaining clearly demonstrated that distributions of SMCT2 and SMCT1 are completely separated in the upstream (S1) and downstream (S2/ S3) of proximal tubules without any mixed expression. This is an ideal arrangement for the effective re-absorption of luminal lactate changing in concentrations. SMCT1-knockout mice displayed a severe loss of lactate in urine (3), indicating that the deficiency of SMCT1 can not be fully compensated by SMCT2.
What monocarboxylates are absorbed via SMCT2?
Since the bacterial fermentation is low in the small intestine, the physiological function of SMCT2 may be to absorb lactate from fermented milk and yoghurt (14) and acetic acid rich in vinegar. SMCT1 and SMCT2 prefer short-chain monocarboxylates containing 2-6 carbon atoms for transport through the plasma membrane, although analysis of SMCT1-knockout mice has suggested that SMCT1 in the colon acts as lactate transporter but not as a transporter for propionate and butylate which are C-3 or C-4 monocarboxylates (3). Nicotinate (niacin, vitamin of SMCT2 in the sodium-coupled uptake of monocarboxylates present in the gut lumen. SGLT1 responsible for glucose uptake is abundantly expressed from the beginning of duodenum to the terminal ileum, being characterized by a broad and considerably consistent distribution on the duodeno-ileal axis (13 and unpublished data by Yoshikawa et al.) . On the crypt-villus axis, the basal region of intestinal villi lacked any significant expression of SMCT2, in contrast to SGLT1 and its abundant expression along the entire length of the villi (also see ref. 1). On both axes, the extension of SMCT2 expression was narrow as compared with that of SGLT1. The arrangement of high affinity SMCT1 and low affinity SMCT2 throughout the gastrointestinal tract is biologically significant, as in the case of the kidney. In the kidney, the differential distribution of SMCT2 in the early parts of proximal tubules and of SMCT1 in the latter parts makes possible the effective re-absorption of lactate and other monocarboxylates (8, 14) . As the net uptake of lactate by the low affinity SMCT2 continues, the luminal concentration of lactate decreases along the proximal tubules and becomes adequate for the high affinity SMCT1. However, immunohistochemistry carried out by Gopal et al. (8) documented that SMCT2 is localized at the brush border from the beginning of the proximal tubules to the late proximal tubules, B 3 ) exists as a monocarboxylate (C-6) anion in vivo and also becomes a substrate to be transported by SMCTs (8, 9, 14) . Thus, SMCTs on the brush border may participate in the active absorption of nicotinate from dietary sources in both the small and large intestine. Lactate and acetate absorbed by SMCT2 in the small intestine may supply an energy source to enterocytes. Furthermore, the epithelium of the small intestine expresses another type of monocarboxylate (MCT1) at the basolateral membrane of cells (see below) and can transfer the absorbed monocarboxylates toward the blood circulation (11) . Since smooth muscles developed in the intestinal wall intensely express the MCT1 with a bidirectional transporting ability, the released monocarboxylates are incorporated by the smooth muscles to support their metabolism.
Comparison with MCT family MCT1 (slc16a1) was first identified as a transporter of monocarboxylates including SCFAs and is localized in the basolateral membrane of intestinal epithelial cells as well as the heart, kidney, and epididymis (4). While SMCT1 (slc5a8) functions as a Na + -coupled electrogenic transporter, MCT1 can transport SCFAs, lactate, and pyruvate in an H + -dependent electroneutral manner. To date, fourteen MCT isoforms have been identified in mammals, each having a unique distribution and different affinity to monocarboxylates (10) . Among them, the present PCR analysis examined MCT1, MCT2, MCT4, and MCT5, whose expression in the gut has been suggested. Reportedly, MCT2 in the digestive tract of hamsters was expressed only in the stomach, where parietal cells were the cellular source (5). The intense expression of MCT2 in the parietal cell area was confirmed by an in situ hybridization study (11) and present PCR analysis at the mRNA level. A Western blot analysis of the human small and large intestines (6) described the intense expression of MCT1, MCT4, and MCT5 in the distal colon, with less intense but significant expressions of all three subtypes in the ileum and proximal colon. The immunoblotting of membrane fractions and immunohistochemistry documented that MCT1 was localized apically and MCT4 and MCT5 were expressed only in the basolateral membranes of enterocytes (6) . However, our quantitative PCR analysis showed only faint expressions of MCT4 and MCT5 throughout the mouse intestine, in agreement with the findings from our in situ hybridization study (11) . Thus, we conclude that MCT1 is a predominant subtype expressed in the gastrointestinal tract of mice, except for MCT2, which is unique to the glandular stomach. 
